1. Inicio
  2. Publicaciones
  3. Effects of Omalizumab Treatment in Patients With Recalcitrant Nasal Polyposis and Mild Asthma: A Multicenter Retrospective Study.

Effects of Omalizumab Treatment in Patients With Recalcitrant Nasal Polyposis and Mild Asthma: A Multicenter Retrospective Study.

Fecha de publicación: Fecha Ahead of Print:

Autores de IIS La Fe

Participantes ajenos a IIS La Fe

  • García-Navalón C
  • Doménech-Campos E
  • Miguel AG
  • Marco-Algarra J
  • Palop-Cervera M

Grupos

Abstract

Chronic rhinosinusitis with nasal polyps (CRSwNP) is a clinical entity with specific features that impacts significantly on patient quality of life (QoL). CRSwNP is often associated with asthma and is difficult to control and manage despite pharmacological and/or surgical treatment. Omalizumab, a monoclonal anti-IgE antibody, has emerged as a putative therapeutic option.

Datos de la publicación

ISSN/ISSNe:
1945-8924, 1945-8932

American Journal of Rhinology & Allergy  SAGE PUBLICATIONS INC

Tipo:
Article
Páginas:
516-524
PubMed:
33153272
Factor de Impacto:
0,861 SCImago ℠
Cuartil:
Q1 SCImago ℠

Citas Recibidas en Web of Science: 28

Documentos

  • No hay documentos

Métricas

Filiaciones mostrar / ocultar

Keywords

  • IgE, SNOT-22, aspirin-exacerbated respiratory disease, chronic rhinosinusitis with nasal polyps, mild asthma, nasal polyps, omalizumab, quality of life, tissue eosinophilia, total nasal endoscopic polyp score

Cita

Compartir